SARA PARTIDA: Open Payments
NPI 1285160622 · ELMHURST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,254 in 93 payments from 19 companies in 2025. Trend: 2023 $2,915 · 2024 $3,927 · 2025 $2,254
Food & beverage: $2,254
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $295 |
| AstraZeneca Pharmaceuticals LP | 5 | $261 |
| Boston Scientific Corporation | 3 | $215 |
| SCPHARMACEUTICALS INC. | 3 | $194 |
| Abbott Laboratories | 3 | $189 |
| CVRx, Inc. | 2 | $166 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $126 |
| PFIZER INC. | 5 | $102 |
| Esperion Therapeutics, Inc. | 5 | $102 |
Products named: LEQVIO, WATCHMAN Access System, FUROSCIX, ELIQUIS, Barostim Neo System, LifeVest, FARXIGA, JOT DX.
Industry payments across IL — which companies pay providers there.
